The pharmaceutical landscape is experiencing a shift with the arrival of GLP-1 delivery devices. These cutting-edge formulations offer a possible method to delivering glucagon-like peptide-1 drugs for individuals living with the disease . Instead of injections , a easy-to-use patch placed to the